RxDoctor Payments Data

Chelsea Roth

Nurse Practitioner · Vernal, UTNPI 1811625239

Payments from drug & device makers

$888in general payments, 2019–2025

Across 41 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • AstraZeneca$179
  • Corcept Therapeutics$110
  • Stimwave Technologies Incorporated$68
  • Indivior Inc.$59
  • Amgen$43
  • plus $77 from 3 others

What the payments were for

  • Food & beverage$888100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$888 in reported general payments places this provider in the 75th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$1,801
Medicare patients
12
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate13$497

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Vernal

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →